Henry Schein
HSIC
Market cap $8.77B

70.19 USD

-0.89

1.25%

At close Jun 13, 4:00 PM EDT

After hours

70.19

+0.00

0.00%

1 day

-1.25%

5 days

-0.26%

1 month

-0.50%

3 months

0.54%

6 months

-8.37%

Year to date

2.39%

1 year

5.92%

5 years

20.64%

10 years

26.90%

About: Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Employees: 25,000

Healthcare Medical Distribution

0

Funds holding %

of 7,296 funds

0

Analysts bullish %

of 3 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

652% more call options, than puts

Call options by funds: $117M | Put options by funds: $15.6M

31% more first-time investments, than exits

New positions opened: 93 | Existing positions closed: 71

10% more funds holding in top 10

Funds holding in top 10: 10 [Q4 2024] → 11 (+1) [Q1 2025]

2% more funds holding

Funds holding: 536 [Q4 2024] → 549 (+13) [Q1 2025]

3% less capital invested

Capital invested by funds: $8.86B [Q4 2024] → $8.62B (-$236M) [Q1 2025]

1.21% less ownership

Funds ownership: 102.63% [Q4 2024] → 101.42% (-1.21%) [Q1 2025]

24% less repeat investments, than reductions

Existing positions increased: 159 | Existing positions reduced: 209

See Fund Rankings

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$75

7%

upside

Avg. target

$79

13%

upside

High target

$86

23%

upside

3 analyst ratings

2 positive

67%

1 neutral

33%

0 negative

0%

Wells Fargo Vik Chopra	7%upside $75	Equal-Weight Maintained	6 May 2025
Barrington Research Michael Petusky	23%upside $86	Outperform Maintained	6 May 2025
Piper Sandler Jason Bednar	10%upside $77	Overweight Maintained	30 Apr 2025

See Analyst Rankings

Financial journalist opinion

Based on 9 articles about HSIC published over the past 30 days

Zacks Investment Research

Here's Why Henry Schein (HSIC) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Henry Schein (HSIC) is a Strong Value Stock

Zacks Investment Research

Here's Why Henry Schein (HSIC) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Henry Schein (HSIC) is a Strong Growth Stock

Zacks Investment Research

Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue?

Updated: Henry Schein to Participate in Upcoming Investor Conference in June

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, at 12:50 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be availab.

Updated: Henry Schein to Participate in Upcoming Investor Conference in June

Zacks Investment Research

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

Zacks Investment Research

Should You Retain Henry Schein Stock in Your Portfolio Right Now?

Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business.

Should You Retain Henry Schein Stock in Your Portfolio Right Now?

Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%

AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One today announced the launch of The 2025 Catalyst Index, its exclusive report offering dental practices an unparalleled view into the strategies transforming performance across the industry. Built on years of trusted benchmarking and informed by Henry Schein One's most connected platform, the fourth annual report, The Catalyst Index, raises the bar by revealing the specific actions that distinguish the top 10% of DSOs and private practices. “.

Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%

Henry Schein Post Earnings Review

HSIC's Q1 earnings were solid, with full-year EPS guidance of $4.80-$4.94 and analysts expecting $5.27 in 2026. New business units and revamped sales incentives aim to reignite revenue growth after stagnation since 2022; management is optimistic about their impact. Ongoing share buybacks (32% reduction in shares since 2011) continue to support EPS and provide downside support for the stock.

Henry Schein Post Earnings Review

Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. “Dan” Daniel,.

Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

Henry Schein to Participate in Upcoming Investor Conference in June

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, 2025, at 1:20 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting https://investor.henryschein.com/webcasts. Replays.

Henry Schein to Participate in Upcoming Investor Conference in June

See News Rankings

Charts implemented using Lightweight Charts™